18f-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: Feasibility study in 60 patients

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 2, 2014, Pages 296-302

  D'Angelillo, Rolando M ^a   Sciuto, Rosa ^b   Ramella, Sara ^a   Papalia, Rocco ^b   Jereczek Fossa, Barbara A ^c,d   Trodella, Luca E ^a   Fiore, Michele ^a   Gallucci, Michele ^b   Maini, Carlo L ^b   Trodella, Lucio ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; DIAGNOSIS; POSITRONS; RADIATION; RADIOTHERAPY; TOXICITY; UROLOGY;

COMMON TERMINOLOGY CRITERIA; GENITOURINARY TOXICITIES; METHODS AND MATERIALS; POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHIES; PROGRESSION FREE SURVIVAL RATES; PROSTATE SPECIFIC ANTIGEN; RADICAL PROSTATECTOMY; SALVAGE RADIATION THERAPIES;

POSITRON EMISSION TOMOGRAPHY;

CHOLINE F 18; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; CHOLINE; FLUORINE; FLUOROMETHYLCHOLINE;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEASIBILITY STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GENITOURINARY TOXICITY; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; PERSONAL EXPERIENCE; PROGRESSION FREE SURVIVAL; PROSTATECTOMY; RADIATION DOSE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SALVAGE THERAPY; TOXICITY; UROGENITAL TRACT DISEASE; ANALOGS AND DERIVATIVES; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; DISEASE COURSE; GASTROINTESTINAL TRACT; IMAGE GUIDED RADIOTHERAPY; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROSTATIC NEOPLASMS; RADIATION RESPONSE; SCINTISCANNING; UROGENITAL SYSTEM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHOLINE; DISEASE PROGRESSION; FEASIBILITY STUDIES; FLUORINE RADIOISOTOPES; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, IMAGE-GUIDED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; UROGENITAL SYSTEM;

EID: 84908247928     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.05.050     Document Type: Article

References (27)

1. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
2. B.S. Carver, F.J. Bianco Jr., and P.T. Scardino Long-term outcome following radical prostatectomy in men with clinical T3 prostate cancer J Urol 176 2006 564 568
3. B. Shekarriz, J. Upadhyay, and D.P. Wood Jr. Vesicourethral anastomosis biopsy after radical prostatectomy: Predictive value of prostate-specific antigen and pathologic stage Urology 54 1999 1044 1048
4. G.P. Swanson, M.A. Hussey, and C.M. Tangen Predominant treatment failure in post-prostatectomy patients is local: Analysis of patterns of treatment failure in SWOG 8794 J Clin Oncol 25 2007 2225 2229
5. J.D. Cox, M.J. Gallagher, and E.H. Hammond Consensus statements on radiation therapy of prostate cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 17 1999 1155
6. A. Heidenreich, P.J. Bastian, and J. Bellmunt EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer Eur Urol 65 2014 467 479
7. A. Stephenson, P. Scardino, and M. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
8. A. Siegmann, D. Bottke, and J. Faehndrich Salvage radiotherapy after prostatectomy - what is the best time to treat? Radiother Oncol 103 2012 239 243
9. C.R. King, and D.S. Kapp Radiotherapy after prostatectomy: Is there evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 71 2008 346 350
10. J.R. Bernard Jr., S.J. Buskirk, and M.G. Heckman Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: Dose-response analysis Int J Radiat Oncol Biol Phys 76 2010 735 740
11. N. Ohri, A.P. Dicker, and E.J. Trabulsi Can early implementation of salvage radiotherapy for prostate cancer improve the therapeutic ratio? A systematic review and regression meta-analysis with radiobiological modelling Eur J Cancer 48 2012 837 844
12. M. Souvatzoglou, B.J. Krause, and A. Pürschel Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer Radiother Oncol 99 2011 193 200
13. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
14. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
15. J.M. Michalski, C. Lawton, and I. El Naqa Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer Int J Radiat Oncol Biol Phys 76 2010 361 368
16. 18F-fluorocholine PET/CT efficacy in early detection of prostate cancer recurrence: preliminary results over 1600 studies Eur J Nucl Mol Imaging 38 Suppl. 2 2011 S111
17. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf.
18. A. Goenka, J.M. Magsanoc, and X. Pei Long-term outcomes after high-dose post-prostatectomy salvage radiation treatment Int J Radiat Oncol Biol Phys 84 2012 112 118
19. R. Schiavina, F. Ceci, and M. Borghesi The dilemma of localizing disease relapse after radical treatment for prostate cancer: Which is the value of the actual imaging techniques? Curr Radiopharm 6 2013 92 95
20. V. Panebianco, F. Barchetti, and A. Sciarra Prostate cancer recurrence after radical prostatectomy: The role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging Eur Radiol 23 2013 1745 1752
21. L. Evangelista, F. Zattoni, and A. Guttilla Choline PET or PET/CT and biochemical relapse of prostate cancer: A systematic review and meta-analysis Clin Nucl Med 38 2013 305 314
22. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 2007 1415 1420
23. 18F-fluorocholine for prostate cancer imaging: A systematic review of the literature Prostate Cancer Prostatic Dis 15 2012 45 55
24. J.S. Park, W. Park, and H.R. Pyo Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Radiother Oncol 110 2014 240 244
25. H.C. Rischke, A.O. Schäfer, and U. Nestle Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endo-rectal coil Radiat Oncol 7 2012 185
26. G. Giovacchini, M. Picchio, and R. Garcia-Parra [11C] choline positron emissiontomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen J Urol 189 2013 105 110
27. F. Buchegger, V. Garibotto, and T. Zilli First imaging results of an intra-individual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy Eur J Nucl Med Mol Imaging 41 2014 68 78